PATENT CLAIM ANALYSIS

Application Number: 16420385
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["435", "007920"]

Abstract:
The present disclosure relates to a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method involves measuring the level of IGFBP7 (Insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level. Further envisaged is a method of monitoring diastolic function in a patient suffering from heart failure. Also encompassed by the present disclosure are kits and devices adapted to carry out the method of the present invention.

Claim (Index 3):
The method according to  claim 1 , wherein the patient suffers from heart failure stage C or D according to the ACC/AHA classification, and/or from heart failure NYHA class III or IV according to the NYHA classification.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 100.0
- Lexical Diversity: 1.66667
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15274533', '15581587', '14818768', '15220555', '12309803']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5483449271494304
- 35 USC 102 Novelty (BERT): 0.6636186277315199
- Combined Prediction Score: 0.5598722972076394
- Mean Citation Score: 325.089296
- Max Citation Score: 634.2080000000002
- Similarity Product: 624.1004944725038

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test